Here are top health stories for the day
India fears for its children as thousands of MBBS students stuck in Ukraine
Amid the growing tension in Ukraine after attack by Russia, thousands of Indian Medical Students who are stuck in the war situation cried for help to the government and requested for their safe return to India.
As per estimates, more than 20,000 Indians are currently staying in Ukraine including thousands of medical students who are pursuing their medical education in the Ukraine based medical universities.
For more information, check out the full story on the link below:
India Fears For Its Children As Thousands Of MBBS Students Stuck In Ukraine
TEQ Rules 2022: NMC spells out foreign PG medical qualifications for equivalence
For doctors, who have PG medical qualifications from foreign countries and intend to enter into a teaching career in India, the National Medical Commission (NMC) has spelt out the basic requirements in its newly released "Teachers Eligibility Qualifications in Medical Institutions Regulations 2022".
Comprehensively laying down the fundamentals for standardising recruitment of doctors towards their entry into medical academia, these TEQ Regulations 2022 published via a gazette issued by the NMC's PG Medical Education Board, are enforceable from February 14th this year.
For more information, check out the full story on the link below:
TEQ Rules 2022: NMC Spells Out Foreign PG Medical Qualifications For Equivalence
No resignation is accepted in or after round 2 NEET, NEET PG counselling 2021: MCC
Through a recent notice, the Medical Counselling Committee (MCC) has clarified that no resignations are allowed once the candidate is a part of round 2 of NEET and NEET PG Counselling for this academic year's medical admissions.
It is for the information of all the candidates & institutes participating in UG /PG Counselling 2021-22 that no resignation is accepted in/after round 2 of counselling.
For more information, check out the full story on the link below:
No Resignation Is Accepted In Or After Round 2 NEET, NEET PG Counselling 2021: MCC
Cipla gets CDSCO panel nod to conduct Indian trials of Paxlovid
In a significant development, drug-major Cipla has got a green signal from the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization (CDSCO) to conduct local trials on the anti-Covid-19 pill Paxlovid.
The SEC of the Central Drugs Standard Control Organization has granted Cipla permission to perform bioavailability and bioequivalence (BA/BE) trials for the anti-Covid-19 pill Paxlovid, as per the report published by ET.
For more information check out the full story on the link below:
Cipla Gets CDSCO Panel Nod To Conduct Indian Trials Of Paxlovid
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.